SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (278)6/12/1998 10:06:00 AM
From: Hyrulean King  Read Replies (3) | Respond to of 5402
 
chirdoc

do you know if the phase 1 product that had fda approval was compatible w/ all blood types? This seems to be a key item for the testing.

chief



To: chirodoc who wrote (278)6/12/1998 10:29:00 AM
From: macker  Read Replies (1) | Respond to of 5402
 
a lipid emulsifier thats easily passable by the system in a short period of time, the recombinant agent releases after so much time in the body, passed through smaller vessels and carried out of the body, no toxicity, no vascular disease potential.

macker


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News